Market Cap | ₹1,941Cr |
ROE | 12.06% |
P/E Ratio(TTM) | 29.78 |
EPS(TTM) | 30.92 |
P/B Ratio | 3.84 |
Dividend Yield | 0.63% |
Industry P/E | 34.33 |
Book Value | 239.99 |
Debt to Equity | 0.06 |
Face Value | 5 |
Parent Organisation | Windlas Biotech |
NSE Symbol | WINDLAS |
COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
---|---|---|---|---|
Torrent Pharmaceuticals | NA (0.00%) | 59.59 | ||
Gland Pharma | NA (0.00%) | 41.49 | ||
Ajanta Pharma | NA (0.00%) | 32.66 | ||
Eris Lifesciences | NA (0.00%) | 56.56 |